News | Artificial Intelligence | March 23, 2020

Vantage Galan 3T the First System in the MR Portfolio with Access to Advanced intelligent Clear-IQ Engine (AiCE)

Advanced intelligent Clear-IQ Engine (AiCE) is pending 510(k) clearance on the Aquilion ONE / PRISM Edition and Aquilion Prime SP CT systems, as well as the Vantage Galan 3T and Vantage Orian 1.5T MR systems

March 23, 2020 — Canon Medical Systems USA, Inc. has received 510(k) clearance on its Advanced intelligent Clear-IQ Engine (AiCE) for the Vantage Galan 3T magnetic resonance imaging (MR) system, further expanding access to its new Deep Learning Reconstruction (DLR) technology. This technology, which is also available across a majority of Canon Medical’s CT product portfolio, uses a deep learning algorithm to differentiate true MR signal from noise so that it can suppress noise while enhancing signal, forging a new frontier for MR image reconstruction.

AiCE was trained using vast amounts of high-quality image data, and features a deep learning neural network that can reduce noise and boost signal to quickly deliver sharp, clear and distinct images, further opening doors for advancements in MR imaging. Capabilities include:

  • High quality images: AiCE allows for the differentiation of true signal from noise through deep learning innovation to match the spatial resolution and low-noise properties of advanced scanning and reconstruction, while maintaining the true structure of the anatomy.
  • Seamless integration into routine practice: AiCE is the world’s first fully integrated deep learning reconstruction for MR, and is built directly into the scan protocols for seamless workflow.
  • Preferred AiCE MR image quality over non-AI reconstruction images: Following a blinded image comparison of AiCE DLR reconstructed images with images reconstructed with conventional methods without AiCE, physicians stated preference for AiCE images for clarity and resolution.

“AiCE utilizes a next generation approach to MR image reconstruction, further proving Canon Medical’s leadership and commitment to innovation in diagnostic imaging,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “With the expansion of this unique DLR method across modalities and into MR, we’re elevating diagnostic imaging capabilities for our customers by bringing the power of AI to routine imaging to provide more possibilities in improving patient care than ever before.”

For more information: www.us.medical.canon


Related Content

News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
News | Digital Pathology

June 15, 2026 — Leica Biosystems is expanding the availability of its Aperio GT Elite digital scanner into the EMEA ...

Time June 15, 2026
arrow
News | Information Technology

June 9, 2026 — Mosaic Clinical Technologies, a wholly owned subsidiary of Radiology Partners, has launched Mosaic ...

Time June 15, 2026
arrow
News | Imaging Software Development

June 10, 2026 — DeepHealth, Inc., a wholly owned subsidiary of RadNet, has launched Reporting Pro, an AI-powered ...

Time June 12, 2026
arrow
News | Radiopharmaceuticals and Tracers

June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...

Time June 01, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
Subscribe Now